Bicuspid aortic stenosis echocardiogram

Revision as of 15:09, 11 April 2012 by Varun Kumar (talk | contribs)
Jump to navigation Jump to search

Bicuspid aortic stenosis Microchapters

Home

Patient Info

Overview

Anatomy

Historical Perspective

Pathophysiology

Epidemiology & Demographics

Risk Factors

Screening

Causes of Bicuspid aortic stenosis

Natural History, Complications & Prognosis

Diagnosis

History & Symptoms

Physical Examination

Lab Tests

Electrocardiogram

Chest X Ray

CT

MRI

Echocardiography

Cardiac Catheterization

Treatment

Overview

Medical Therapy

Surgery

Bicuspid aortic stenosis echocardiogram On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Bicuspid aortic stenosis echocardiogram

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Bicuspid aortic stenosis echocardiogram

CDC on Bicuspid aortic stenosis echocardiogram

Bicuspid aortic stenosis echocardiogram in the news

Blogs on Bicuspid aortic stenosis echocardiogram

Directions to Hospitals Treating Bicuspid aortic stenosis

Risk calculators and risk factors for Bicuspid aortic stenosis echocardiogram

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-In-Chief: Varun Kumar, M.B.B.S. [2]

Overview

Two dimensional echocardiography plays an important role in the diagnosis of bicuspid aortic stenosis. Bicuspid aortic stenosis is important to diagnose because of the associated risk of endocarditis and the risk of progressive valvular stenosis.

Echocardiographic Findings in Bicuspid Aortic Valve Disease

  • The short axis view is useful, but doming of valve can best be seen on the parasternal long axis.
  • Echocardiographic features that are associated with a poor prognosis in asymptomatic patients and progression to a symptomatic state include moderate to severe calcification and a peak aortic velocity > 4.0 M/s. [1]


  • Bicuspid Aortic Valve by Transesophageal Echo 1

{{#ev:googlevideo|3292040052828332033&hl=en}}

  • Bicuspid Aortic Valve by Transesophageal Echo 2

{{#ev:googlevideo|-391308719590697542&hl=en}}

  • Bicuspid Aortic Valve by Transesophageal Echo 3

{{#ev:googlevideo|2514293818722256502&hl=en}}

  • Bicuspid Aortic Valve by Transesophageal Echo 4

{{#ev:googlevideo|3670690104304937807&hl=en}}

  • Bicuspid Aortic Valve by Transesophageal Echo 5

{{#ev:googlevideo|2955895618088483909&hl=en}}

  • Bicuspid Aortic Valve by Transesophageal Echo 6

{{#ev:googlevideo|895529287972799768&hl=en}}

  • Bicuspid Aortic Valve by Transesophageal Echo 7

{{#ev:googlevideo|-1456550005760918044&hl=en}}

ACC/AHA Guidelines for Echocardiographic Evaluation and Monitoring of Asymptomatic Adults with Aortic Stenosis Secondary to Either Bicuspid or Degenerative Tricuspid Disease[2]

Class I

1. Doppler echocardiography is recommended yearly in the asymptomatic adolescent or young adult with AS who has a Doppler mean gradient greater than 30 mm Hg or a peak velocity > 3.5 m per second (peak gradient > 50 mm Hg) and every 2 years if the Doppler gradient is ≤ 30 mm Hg or the peak jet velocity is ≤ 3.5 m per second (peak gradient ≤ 50 mm Hg). (Level of Evidence: C)

2. Transthoracic echocardiography is recommended for re-evaluation of asymptomatic patients: every year for severe AS; every 1 to 2 years for moderate AS; and every 3 to 5 years for mild AS. (Level of Evidence: B)

References

  1. Cohn LH, Edmunds LH Jr. Cardiac Surgery in the Adult. McGraw-Hill, 2003.
  2. Bonow RO, Carabello BA, Chatterjee K, de Leon AC, Faxon DP, Freed MD, Gaasch WH, Lytle BW, Nishimura RA, O'Gara PT, O'Rourke RA, Otto CM, Shah PM, Shanewise JS (2008). "2008 Focused update incorporated into the ACC/AHA 2006 guidelines for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 1998 Guidelines for the Management of Patients With Valvular Heart Disease): endorsed by the Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons". Circulation. 118 (15): e523–661. doi:10.1161/CIRCULATIONAHA.108.190748. PMID 18820172. Retrieved 2012-04-11. Unknown parameter |month= ignored (help)

Template:WH Template:WS